datetime,headline,summary,related,lang,source
2020-11-26 07:56:15-05:00,"Routemaster Capital Types and Strengthens Advisory Board With Former Government at Alibaba Group and Yahoo!, Trapp Lewis TSX Ent","Routemaster Capital Types and Strengthens Advisory Board With Former Government at Alibaba Group and Yahoo!, Trapp Lewis TSX Enterprise Trade:RM -",RM,en,Fintech Zoom
2020-10-29 14:40:00-05:00,Regional Management Does Earnings Surprise History Hold Any Clue for Stock market Insights & financial analysis,"Regional Management announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…",RM,en,Stock Market Daily
2020-10-24 20:34:41-05:00,Regional Management Corp. (NYSE:RM) Expected to Announce Quarterly Sales of $84.62 Million,"Equities analysts predict that Regional Management Corp. (NYSE:RM) will post sales of $84.62 million for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for Regional Management’s earnings. The highest sales estimate is $88.39 million and the lowest is $80.84 million. Regional Management posted sales of $91.71 million in the […]",RM,en,US Banking News
2020-09-10 15:15:00-05:00,"Regional Management Corp. Provides Business Update as of August 31, 2020","GREENVILLE, S.C.--(BUSINESS WIRE)--Regional Management Corp. (NYSE: RM), a diversified consumer finance company, today provided an update on its business operations and financial position. As of August 31, 2020, our credit profile remains stable, demand for our loan products continues to rebound, our balance sheet remains strong, and we maintain access to ample liquidity to fund our business operations and growth. Our proven operating model and financial strength enable us to continue to provid",RM,en,Business Wire
2020-07-13 08:16:16-05:00,Reno De Medici S p A : Update on the execution of the Buy-Back Program | MarketScreener,"Press Release Reno De Medici S.p.A.: update on the execution of the buyback program PURCHASES IN THE PERIOD FROM JULY 6 - JULY 10, 2020 … | July 13, 2020",RM,en,MarketScreener
2020-06-03 16:00:00-05:00,Regional Management Corp. Provides Business Update,"GREENVILLE, S.C.--(BUSINESS WIRE)--Regional Management Corp. (NYSE: RM), a diversified consumer finance company, today provided an update on its business operations and financial position as of May 31, 2020. Our top priority continues to be the health and well-being of our customers and team members as states relax their stay-at-home orders and reopen their economies. Our branch personnel and centralized collections team, aided by our digital capabilities, have provided largely uninterrupted su",RM,en,Business Wire
2020-04-30 10:50:21-05:00,Are Investors Undervaluing Regional Management (RM) Right Now?,"Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",RM,en,Zacks Investment Research
2020-04-28 16:45:19-05:00,Regional Management (RM) Gains As Market Dips: What You Should Know,"In the latest trading session, Regional Management (RM) closed at $14.66, marking a +0.69% move from the previous day.",RM,en,Zacks Investment Research
2020-04-23 09:50:00-05:00,"The Zacks Analyst Blog Highlights: Avid Technology, Cornerstone Building Brands, CURO Group, Build-A-Bear Workshop and Regional Management","The Zacks Analyst Blog Highlights: Avid Technology, Cornerstone Building Brands, CURO Group, Build-A-Bear Workshop and Regional Management",RM,en,Zacks Investment Research
2020-04-22 11:45:07-05:00,"Is Regional Management (RM) a Solid Growth Stock? 3 Reasons to Think "" Yes """,Regional Management (RM) could produce exceptional returns because of its solid growth attributes.,RM,en,Zacks Investment Research
2020-03-30 11:45:05-05:00,3 Reasons Growth Investors Will Love Regional Management (RM),Regional Management (RM) could produce exceptional returns because of its solid growth attributes.,RM,en,Zacks Investment Research
2020-02-25 18:15:04-05:00,Regional Management (RM) Q4 Earnings and Revenues Surpass Estimates,"Regional Management (RM) delivered earnings and revenue surprises of 27.78% and 4.16%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?",RM,en,Zacks Investment Research
2020-02-25 16:19:49-05:00,"Regional Management EPS beats by $0.26, beats on revenue",Regional Management (NYSE:RM): Q4 GAAP EPS of $1.38 beats by $0.26. Revenue of $97.98M (+17.0% Y/Y) beats by $3.13M. Press Release,RM,en,Seeking Alpha
2019-12-30 06:59:00-05:00,Regional Management Sees Hammer Chart Pattern: Time to Buy?,"Regional Management has been struggling lately, but the selling pressure may be coming to an end soon.",RM,en,Zacks Investment Research
2019-12-13 08:10:02-05:00,"The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third Approval, NewLink Genetics Rejects Competing Offer","The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Dec. 12.) Allergan plc (NYSE: AGN ) Amgen, Inc. (NASDAQ: AMGN ) (received approval for its bone-building osteoporosis drug in the U.S.) Aprea Therapeutics Inc (NASDAQ: APRE ) Aptose Biosciences Inc (NASDAQ: APTO ) Aurinia Pharmaceuticals Inc (NASDAQ: AUPH ) Avenue Therapeutics Inc (NASDAQ: ATXI ) (submitted the NDA for intravenous tramadol for the management of moderate to moderately severe pain in adults in a medically supervised health care setting) Bausch Health Companies Inc (NYSE: BHC ) (reacted to upgrade to Overweight rating by JPMorgan) BioNTech SE – ADR (NASDAQ: BNTX ) Bio-Rad Laboratories, Inc. Class A (NYSE: BIO ) Boston Scientific Corporation (NYSE: BSX ) Bristol-Myers Squibb Co (NYSE: BMY ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) Eidos Therapeutics Inc (NASDAQ: EIDX ) ESSA Pharma Inc (NASDAQ: EPIX ) Flexion Therapeutics Inc (NASDAQ: FLXN ) Forty Seven Inc (NASDAQ: FTSV ) Globus Medical Inc (NYSE: GMED ) (reacted to upgrade to Overweight by Wells Fargo Securities) Gossamer Bio Inc (NASDAQ: GOSS ) Hologic, Inc.","RMD,RM",en,Benzinga Feeds
2019-11-25 03:30:00-05:00,Is Regional Management (RM) a Great Pick for Value Investors?,Let's see if Regional Management (RM) stock is a good choice for value-oriented investors right now from multiple angles.,RM,en,Zacks Investment Research
2019-11-06 18:55:18-05:00,Regional Management (RM) Q3 Earnings and Revenues Top Estimates,"Regional Management (RM) delivered earnings and revenue surprises of 9.09% and 4.48%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?",RM,en,Zacks Investment Research
2019-11-05 13:35:50-05:00,Is Regional Management Corp (RM) A Good Stock To Buy?,"Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and outperform the bull market that we have witnessed in recent years. However, hedge funds are generally",RM,en,ACI Information Group
2019-10-30 09:33:39-05:00,Regional Management (RM) Reports Next Week: Wall Street Expects Earnings Growth,Regional Management (RM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,RM,en,Zacks Investment Research
2019-09-06 06:27:25-05:00,"The Daily Biotech Pulse: European Nod For Roche, Takeda Recall, Neon Exults On Journal Publication","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Sept. 5) Bioanalytical Systems, Inc. (NASDAQ: BASI ) NextCure Inc (NASDAQ: NXTC ) Pfenex Inc (NYSE: PFNX ) Protagonist Therapeutics Inc (NASDAQ: PTGX ) ResMed Inc. (NYSE: RMD ) West Pharmaceutical Services Inc. (NYSE: WST ) Down In The Dumps (Biotech stocks hitting 52-week lows on Sept. 5) Adamis Pharmaceuticals Corp (NASDAQ: ADMP ) BioNano Genomics Inc (NASDAQ: BNGO ) Endologix, Inc. (NASDAQ: ELGX ) Mallinckrodt PLC (NYSE: MNK ) ( retreated amid reports of restructuring ahead of Cleveland opioid litigation) Merit Medical Systems, Inc. (NASDAQ: MMSI ) VBI Vaccines Inc (NASDAQ: VBIV ) Zafgen Inc (NASDAQ: ZFGN ) ( announced decision to explore strategic options) See Also: Biotech Stock On The Radar: Ardelyx Gears Up For FDA Decision Day Stocks In Focus Neon's Process To Predict Neoantigens To Control Tumor Growth Published In Scientific Journal Neon Therapeutics Inc (NASDAQ: NTGN ) announced publication in the scientific journal ""Immunity,"" a breakthrough process for predicting which neoantigens will be presented by MHC Class II molecules in the tumor microenvironment.","RMD,RM",en,Benzinga
2019-08-30 07:28:27-05:00,"The Daily Biotech Pulse: Genmab-Novartis Multiple Sclerosis Drug Aces Late-Stage Studies, Akari Nets Orphan Drug Designation","The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Aug. 30.) Inspire Medical Systems Inc (NYSE: INSP ) NextCure Inc (NASDAQ: NXTC ) Radius Health Inc (NASDAQ: RDUS ) ResMed Inc. (NYSE: RMD ) Stoke Therapeutics Inc (NASDAQ: STOK ) Down In The Dumps (Biotech stocks that hit 52-week lows on Aug. 30.) ContraFect Corp (NASDAQ: CFRX ) Ekso Bionics Holdings Inc (NASDAQ: EKSO ) Rubius Therapeutics Inc (NASDAQ: RUBY ) Trinity Biotech plc (NASDAQ: TRIB ) Stocks In Focus Genmab-Novartis' Multiple Sclerosis Drug Found Superior To Sanofi's GENMAB A/S/S ADR (NASDAQ: GMAB ), which recently listed its shares in the U.S., said Novartis AG (NYSE: NVS ), its partner in the development of atumumab, has reported positive results … Full story available on Benzinga.com","RMD,RM",en,Benzinga
2019-08-26 09:06:00-05:00,Moving Average Crossover Alert: Regional Management,"Regional Management Corp. (RM) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.",RM,en,Zacks Investment Research
2019-07-31 19:15:09-05:00,Regional Management (RM) Q2 Earnings and Revenues Beat Estimates,"Regional Management (RM) delivered earnings and revenue surprises of 7.69% and 4.70%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?",RM,en,Zacks Investment Research
2019-07-24 09:32:58-05:00,Analysts Estimate Regional Management (RM) to Report a Decline in Earnings: What to Look Out for,Regional Management (RM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,RM,en,Zacks Investment Research
2019-07-02 06:29:04-05:00,"The Daily Biotech Pulse: Celyad To Advance Leukemia Drug To Clinical Trial, Positive Data For Teva's Migraine Drug","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 1) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) Argenx SE – ADR (NASDAQ: ARGX ) ArQule, Inc. (NASDAQ: ARQL ) Axsome Therapeutics Inc (NASDAQ: AXSM ) (the company's stock has been added to Russell 3000 and Russell 2000 Indexes) Coherus Biosciences Inc (NASDAQ: CHRS )(announced that it has produced over 400,000 Udenyca pre-filled syringes to date) Fate Therapeutics Inc (NASDAQ: FATE ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) MeiraGTx Holdings PLC (NASDAQ: MGTX ) Misonix, Inc. (NASDAQ: MSON ) (the company's stock has been added to Russell 3000 and Russell 2000 Indexes) Morphic Holding Inc (NASDAQ: MORF )(IPOed June 27) Odonate Therapeutics Inc (NASDAQ: ODT ) Ra Pharmaceuticals Inc (NASDAQ: RARX ) ResMed Inc. (NYSE: RMD ) Tricida Inc (NASDAQ: TCDA ) Vapotherm Inc (NYSE: VAPO ) Zai Lab Ltd (NASDAQ: ZLAB ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 1) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Artelo Biosciences Inc (NASDAQ: ARTL ) CELLECT …",RM,en,Benzinga
2019-06-21 06:18:48-05:00,"The Daily Biotech Pulse: ContraVir's Volatile Ride Continues, Late-Stage Disappointment For Exelixis, Regeneron-Sanofi Breathe Easy","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 20) Abbott Laboratories (NYSE: ABT ) ANI Pharmaceuticals Inc Common Stock (NASDAQ: ANIP ) argenx SE – ADR (NASDAQ: ARGX ) ArQule, Inc. (NASDAQ: ARQL ) Celgene Corporation (NASDAQ: CELG ) Coherus Biosciences Inc (NASDAQ: CHRS ) DiaMedica Therapeutics Inc (NASDAQ: DMAC )( reported positive interim results from a Phase 1b study of its DM199, which is being evaluated for moderate-to-severe chronic kidney disease) Edesa Biotech Inc (NASDAQ: EDSA )(FDA gave the go ahead to start a Phase 2b trial for EB01, its lead candidate being evaluated for chronic allergic contact dermatitis) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Hologic, Inc. (NASDAQ: HOLX ) Repligen Corporation (NASDAQ: RGEN ) ResMed Inc. (NYSE: RMD ) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech stocks hitting 52-week lows on June 20) Abeona Therapeutics Inc (NASDAQ: ABEO ) Adial Pharmaceuticals Inc (NASDAQ: ADIL ) AMAG Pharmaceuticals, Inc.","RGEN,RMD,RM",en,Benzinga
2019-06-20 06:25:13-05:00,"The Daily Biotech Pulse: DiaMedica Reports Positive Data For Chronic Kidney Disease Drug, Eloxx Offering, IPO Deluge","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 19) Abbott Laboratories (NYSE: ABT ) CareDx Inc (NASDAQ: CDNA ) CONMED Corporation (NASDAQ: CNMD ) DENTSPLY SIRONA Inc (NASDAQ: XRAY ) Hologic, Inc. (NASDAQ: HOLX ) Insulet Corporation (NASDAQ: PODD ) Merck & Co., Inc. (NYSE: MRK )(reports suggested that the company is on the look out to find a replacement for its CEO Ken Frazier) Novocure Ltd (NASDAQ: NVCR ) Repligen Corporation (NASDAQ: RGEN ) ResMed Inc. (NYSE: RMD ) ZIOPHARM Oncology Inc. (NASDAQ: ZIOP ) Zynex Inc. (NASDAQ: ZYXI ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech stocks hitting 52-week lows on June 19) Abeona Therapeutics Inc (NASDAQ: ABEO ) CELYAD SA/ADR (NASDAQ: CYAD ) ContraVir Pharmaceuticals Inc (NASDAQ: CTRV ) Jaguar Health Inc (NASDAQ: JAGX ) Spring Bank Pharmaceuticals Inc (NASDAQ: SBPH ) Surface Oncology Inc (NASDAQ: SURF ) Stocks In Focus DiaMedica Drug Found Safe And Effective Against Chronic Kidney Disease DiaMedica Therapeutics Inc (NASDAQ: DMAC ) announced interim results from the Phase 1b study of its DM199, which is being evaluated for moderate-to-severe chronic …","RGEN,RMD,RM",en,Benzinga
2019-06-06 08:30:00-05:00,Should Value Investors Pick Regional Management (RM) Stock?,Let's see if Regional Management (RM) stock is a good choice for value-oriented investors right now from multiple angles.,RM,en,Zacks Investment Research
2019-05-12 02:05:52-05:00,Regional Management Corp. (RM) CEO Peter Knitzer on Q1 2019 Results - Earnings Call Transcript,"Regional Management Corp. (NYSE:RM) Q1 2019 Results Earnings Conference Call May 08, 2019, 05:00 PM ET Company Participants Garrett Edson - SVP, ICR Peter Knitz",RM,en,Seeking Alpha
2019-05-10 13:07:08-05:00,Regional Management Corp. 2019 Q1 - Results - Earnings Call Slides,No summary available.,RM,en,Seeking Alpha
2019-05-08 21:23:58-05:00,Regional Management (RM) Q1 2019 Earnings Call Transcript,"RM earnings call for the period ending March 31, 2019.",RM,en,The Motley Fool
2019-05-08 19:25:04-05:00,Regional Management (RM) Q1 Earnings and Revenues Lag Estimates,"Regional Management (RM) delivered earnings and revenue surprises of -15.19% and -3.82%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?",RM,en,Zacks Investment Research
2019-05-08 15:42:24-05:00,"Regional Management misses by $0.11, misses on revenue",No summary available.,RM,en,Seeking Alpha
2019-05-01 09:32:57-05:00,Regional Management (RM) Earnings Expected to Grow: Should You Buy?,Regional Management (RM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,RM,en,Zacks Investment Research
2019-02-22 11:50:19-05:00,Regional Management +1.3% as BTIG initiates at buy,No summary available.,RM,en,Seeking Alpha
2019-02-13 05:15:18-05:00,Regional Management CFO to retire,No summary available.,RM,en,Seeking Alpha
